Redmile Group, LLC - 16 Jun 2023 Form 4 Insider Report for MedAvail Holdings, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Jun 2023, 21:45:30 UTC
Prior SEC filing
16 Jun 2023
Next SEC filing
28 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC

Key filing fact

Redmile Group, LLC filed Form 4 for MedAvail Holdings, Inc. on 21 Jun 2023.

Key facts

  • This page summarizes Redmile Group, LLC's Form 4 filing for MedAvail Holdings, Inc..
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 21 Jun 2023, 21:45.

Change

  • Previous filing in this sequence was filed on 16 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDVL transaction Derivative

Series A Warrants to Purchase Common Stock

Award

Transaction value
Shares
+38,916,562
Change %
Price
Shares after
38,916,562
Date
16 Jun 2023
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
38,916,562
Exercise price
$0.3854
Footnotes
F1, F2, F3
MDVL transaction Derivative

Series A Warrants to Purchase Common Stock

Award

Transaction value
Shares
+38,916,562
Change %
Price
Shares after
38,916,562
Date
16 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
38,916,562
Exercise price
$0.3854
Footnotes
F1, F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On June 16, 2023, the Issuer issued Series A Warrants to purchase up to an aggregate of 38,916,562 shares of the Issuer's common stock (the "Series A Warrant Shares") to RedCo II Master Fund, L.P. ("RedCo II"), a private investment vehicle managed by Redmile Group, LLC ("Redmile"). RedCo II acquired the right to receive the Series A Warrants pursuant to a securities purchase agreement, dated as of March 9, 2023 (the "Purchase Agreement"), in connection with a private placement of securities by the Issuer to certain investors on March 13, 2023 (the "Private Placement"). The issuance of the Series A Warrants under the Purchase Agreement was subject to stockholder approval under the applicable rules of The Nasdaq Stock Market LLC, which was obtained at the annual meeting of the Issuer's stockholders held on June 14, 2023.

Footnote F2

The Warrants are exercisable by a holder at any time on or after June 16, 2023 for a five-year term that expires on June 16, 2028 at an exercise price of $0.38544 per share.

Footnote F3

These securities are directly owned by RedCo II and may be deemed beneficially owned by Redmile as investment manager of RedCo II. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the "Reporting Persons"). Each of Reporting Persons disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that such Reporting Persons are a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Footnote F4

RedCo II acquired the Warrants directly in the Private Placement pursuant to the terms of the Purchase Agreement.

SEC remarks

Rob Faulkner, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile and its affiliates. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .